Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,375.00    -80.00 (-1.47%)
Bid:
5,355.00
Ask:
5,370.00
Spread: 15.00 (0.28%)
Market Cap: £3.91b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Trading Statement

18 Oct 2018 07:00

RNS Number : 4018E
Renishaw PLC
18 October 2018
 

Renishaw plc

Trading update

18th October 2018

Renishaw plc, the global high-precision metrology and healthcare technology group, publishes this trading update for the three months ended 30th September 2018. It contains unaudited information that covers the first quarter and the period since.

 

Trading activity

 

Continuing operations

First quarter2019

First quarter2018

Change

Metrology

£147.4m

£137.1m

+8%

Healthcare

£6.6m

£5.2m

+27%

Total revenue

£154.0m

£142.3m

+8%

 

Adjusted* profit before tax

£32.6m

£35.8m

-9%

Statutory profit before tax

£33.5m

£36.9m

-9%

 

Revenue from continuing operations for the first quarter of the current financial year was £154.0m, a growth of 8% over the £142.3m for the corresponding period last year. We experienced growth for the period at constant exchange rates of 7% with growth in all regions.

 

In our metrology business revenue amounted to £147.4m compared to £137.1m last year, with growth at constant exchange rates of 7%. Revenue in our healthcare business was £6.6m compared with £5.2m last year, a growth of 25% at constant exchange rates.

 

The Adjusted* profit before tax from continuing operations for the first quarter amounted to £32.6m compared with £35.8m last year and the statutory profit before tax amounted to £33.5m (2018: £36.9m).

 

Over recent years, we have invested in people and infrastructure to support growth opportunities and are now well placed to benefit from these investments. We anticipate the rate of investment in additional resources will reduce in the remainder of the current financial year as we continue to monitor the Group's cost base.

 

Financial position 

The Group balance sheet remains strong with net cash balances of £115.3m as at 30th September 2018 compared to £103.8m at 30th June 2018.

 

Outlook

Despite the potential impacts of Brexit and economic uncertainties in Asia the Board remains confident in the future prospects of the Group and of growth in both revenue and profit in this financial year.

The results for the half year ending 31st December 2018 will be released on 31st January 2019.

 

Sir David McMurtry

William Lee

CBE, RDI, FRS, FREng, CEng, FIMechE

Chief Executive Officer

Executive Chairman

 

 

 

18th October 2018

 

 

 

 

 

 

Renishaw plc

 

Registered office

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number

1106260

LEI number

21380048ADXM6Z67CT18

Telephone number

01453 524524

Website

www.renishaw.com

 

 

 

 

* Adjusted profit before tax

 

 

The adjustment to statutory profit relates to the accounting treatment of certain forward currency contracts used as hedging instruments which do not qualify for hedge accounting as they do not meet the hedge effectiveness criteria set out in the International Accounting Standard IFRS9 'Financial Instruments', or the criteria set out in IAS39 'Financial Instruments: Recognition and Measurement' used in the prior year. The Board deems that the adjusted profit before tax better reflects the underlying performance of the Group. The following table reconciles statutory profit before tax to adjusted profit before tax:

 

 

 

 

 

 

£'m

Q1 2019

 

Q1 2018

 

 

 

 

 

 

 

 

Adjusted profit before tax

32.6

 

35.8

 

 

 

 

Fair value gains/losses on financial instruments not eligible for hedge accounting

 

 

 

- reported in revenue

1.8

 

0.1

- reported in (losses)/gains from the fair value of financial instruments

(0.9)

 

1.0

 

 

 

 

Statutory profit before tax from continuing operations

33.5

 

36.9

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAKEXFLKPFFF
Date   Source Headline
6th May 20267:00 amRNSTrading Statement
20th Apr 20267:00 amRNSTrading Statement
8th Apr 20267:00 amRNSBoard Changes
11th Feb 20267:00 amRNSHalf-year Financial Report
29th Jan 202612:00 pmRNSNotice of Half-year Results
28th Nov 202511:00 amRNSHolding(s) in Company
28th Nov 202511:00 amRNSHolding(s) in Company
27th Nov 20256:29 pmRNSHolding(s) in Company
27th Nov 20255:00 pmRNSDirector/PDMR Shareholding
26th Nov 20251:32 pmRNSResult of AGM
26th Nov 20258:30 amRNSShareholdings update
29th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSTrading Statement
21st Oct 20253:02 pmRNSVoting Arrangement
21st Oct 20253:00 pmRNSHolding(s) in Company
21st Oct 20253:00 pmRNSHolding(s) in Company
3rd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSNew reporting segments for FY2026
18th Sep 20257:00 amRNSFinal Results
21st Aug 20257:00 amRNSBoard Change and Trading Update
13th Aug 20257:00 amRNSDirectorate Change
17th Jun 20257:00 amRNSCapital Markets Day
8th May 20257:00 amRNSTrading Statement
14th Apr 20259:49 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSHalf-year Report
9th Dec 20242:02 pmRNSDeath of Sir David McMurtry
27th Nov 20242:44 pmRNSResult of AGM
29th Oct 20241:28 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSTrading Statement
27th Sep 20247:15 amRNSAnnual Financial Report
12th Sep 20247:00 amRNSFinal Results
29th Aug 20242:00 pmRNSNotice of Results
1st Jul 20247:00 amRNSDirectorate Change
13th Jun 20247:00 amRNSDirectorate Change
16th May 20242:25 pmRNSAGM Voting Results Update Statement
8th May 20247:00 amRNSTrading Statement
2nd Apr 20245:19 pmRNSStatement regarding Renishaw plc
6th Feb 20247:00 amRNSHalf-year Report
30th Jan 202410:30 amRNSChange of Adviser
23rd Jan 20249:00 amRNSNotice of Half-year Results
29th Nov 20232:47 pmRNSResult of AGM
26th Oct 20237:00 amRNSTrading Statement
13th Oct 20237:00 amRNSNotice of AGM
3rd Oct 20237:00 amRNSAnnual Financial Report
19th Sep 20237:00 amRNSFinal Results
13th Sep 20237:00 amRNSRevised date for publication of results
21st Aug 20233:00 pmRNSDirectorate Change
12th Jul 20232:30 pmRNSVoting Arrangement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.